Kurokawa Y, Uede T, Niwa J, Daibo M, Hashi K
Department of Neurosurgery, Sapporo Medical University School of Medicine, Japan.
No Shinkei Geka. 1998 Sep;26(9):813-21.
Pituitary macroadenomas which required transcranial removal were reviewed concerning visual acuity outcome as well as recurrence. We encountered 173 pituitary adenomas of which 27 (15.6%) were removed transcranially during the past 13 years. Eight cases were excluded due to inadequate information and improper utilization. Thus, a total of nineteen cases were reviewed in which the frontotemporal (FT) approach was utilized for seven cases and the interhemispheric (IH) approach for 12 cases. The mean size and volume of the tumors in the FT group were 3.0 x 3.7 x 3.1 cm and 18.2 cm3. The main reason for utilizing this approach was the fact that the tumors extended laterally involving the unilateral cavernous sinus or that unilateral preoperative visual acuity was obstructed. The visual acuity outcome was as follows: In six cases showing useful visual acuity on both sides before surgery, no apparent aggravation on either side was found in four cases, while in two cases there was complete obstruction on the operative side. The remaining case showed aggravation on both sides, though the approach side was decided upon because of the obstructed vision on that side. The mean size and volume of the tumors in the IH group were 4.6 x 4.8 x 4.9 cm and 71.1 cm3. This approach was used due to the extreme suprasellar extension because of the large size of the tumors. Although the tumors were relatively large and the visual acuity was assessed as fair prior to surgery, visual acuity showed no significant deterioration after the operation and was found to be satisfactory in 11 out of 12 cases. The complications in the FT group were oculomotor palsy in 3 cases, hemorrhage in one case, and frontal infarction in one case. On the other hand, three cases suffered hemorrhage in the tumor cavity of the IH group, though none needed surgical evacuation. Most of the cases in the IH group showed pituitary hypofunction following the surgical removal of the tumors as compared to the cases in the FT group. Recurrence had occurred, in some cases, several years after the operation. Furthermore, some of the tumors are still growing larger following only partial or subtotal removal. The prime aim of the treatment for huge pituitary adenomas which require the transcranial removal is to retain as much visual acuity as possible. In conclusion, the IH approach has been shown to be preferable in this situation. The FT approach was found to be more dangerous in terms of visual outcome than had been expected, even if the tumors were not particularly large.
对需要经颅切除的垂体大腺瘤的视力预后及复发情况进行了回顾性研究。在过去13年中,我们共诊治173例垂体腺瘤,其中27例(15.6%)经颅切除。因信息不充分及利用不当排除8例。因此,共回顾了19例,其中7例采用额颞(FT)入路,12例采用半球间(IH)入路。FT组肿瘤的平均大小和体积分别为3.0×3.7×3.1 cm和18.2 cm³。采用该入路的主要原因是肿瘤向外侧扩展累及单侧海绵窦或术前单侧视力受阻。视力预后如下:术前双侧视力有用的6例中,4例双侧无明显加重,2例手术侧完全失明。其余1例双侧视力加重,尽管因该侧视力受阻而选择了手术入路。IH组肿瘤的平均大小和体积分别为4.6×4.8×4.9 cm和71.1 cm³。由于肿瘤巨大导致鞍上极度扩展,故采用该入路。尽管肿瘤相对较大且术前视力评估尚可,但术后视力无明显恶化,12例中有11例视力满意。FT组并发症包括3例动眼神经麻痹、1例出血和1例额叶梗死。另一方面,IH组有3例肿瘤腔内出血,不过均无需手术清除。与FT组相比,IH组大多数病例术后出现垂体功能减退。部分病例术后数年出现复发。此外,部分肿瘤仅行部分或次全切除后仍在继续增大。对于需要经颅切除的巨大垂体腺瘤,治疗的主要目标是尽可能保留视力。总之,在这种情况下,IH入路更可取。FT入路在视力预后方面比预期更危险,即使肿瘤并非特别大。